DOW
loading...
NASDAQ
loading...
S&P
loading...




Action Alerts PLUS
RealMoney Silver
Market Movers
Stocks Under $10
Options Alerts
Breakout Stocks
View All


Now, enjoy the good life every day!

RSSRSS FEEDS
PODPODCASTS


RealMoney.com: Jim Cramer Blog
Print This Story

Learn the Truth About the UltraShorts

By Jim Cramer
RealMoney Columnist

2/27/2009 3:59 PM EST
Click here for more stories by Jim Cramer
 
Try Jim Cramer's Action Alerts PLUS
CLICK HERE NOW

Holy cow, I am not paranoid. There is a conspiracy to knock down stocks! OK, that's extreme, but you have to recognize that this incredible bear market that is clawing away at so many sectors does coincide with the elimination of the uptick rule, coupled with the creation of these bear market Ultra ETFs that control so much of trading.

 
I say that after reading the amazing history of these products and the uptick rule presented by Eric Oberg on this site. He did some homework on this one. The byzantine approval process coupled with the "research" done to get around the margin rules and the short rules just drives me crazy. You couple this one with the letter that Eddie Lampert issued yesterday for his Sears (SHLD - commentary - Cramer's Take) quarter, one of the wildest and truest documents I have come across.

Lots of people have been all over me, saying the uptick rule doesn't matter at all, but that's just not rigorous. Do you really believe that something like the ProShares UltraShort Financials ETF (SKF - commentary - Cramer's Take) could have been approved without the uptick demolition?

I urge you to read this piece. I think it is the most important discussion on the issue, and it is part and parcel with a market that's been cut in half and very well could be cut in half again over time.

These instruments may not have much to do with the direction. That's the fundamentals. But the velocity has, in many ways, wrecked the ability of companies to issue equity. And that's a crime enough.

At the time of publication, Cramer had no positions in stocks mentioned.

Random musings: Biotech orphan drugs without generic competition or without competition at all will not likely be affected by Obama. That's where the opportunities are, because they have been totally hammered. ... Lincoln National (LNC - commentary - Cramer's Take), MetLife (MET - commentary - Cramer's Take), Prudential (PRU - commentary - Cramer's Take), Hartford (HIG - commentary - Cramer's Take), Principal Financial (PFG - commentary - Cramer's Take)? These have come to resemble MBIA (MBI - commentary - Cramer's Take), Ambac (ABK - commentary - Cramer's Take), PMI Group (PMI - commentary - Cramer's Take) and MGIC (MTG - commentary - Cramer's Take), and I believe that some of these will ultimately have to be put in receivership. I cannot emphasize how dangerous this is for the American people who don't even know their annuities could be at risk. I am sure the reporters who told Tim Geithner to cancel the Citigroup (C - commentary - Cramer's Take) preferreds didn't realize what it would do to the insurers who rely on that funding. To me it is a nightmare.






 RELATED STORIES

Jim Cramer Blog
GE Dividend Cut Relieves the Pressure
2/27/2009 2:40 PM EST
Bottom line -- the stock is healthier today than it was yesterday.

Jim Cramer Blog
You Have to Wait on Biotech Plays
2/27/2009 1:29 PM EST
It's too early to buy and too late to short, but the Obama issue could be a bugbear.

Jim Cramer Blog
Don't Need Stocks? Don't Own 'Em
2/27/2009 6:30 AM EST
If you need money for anything important anytime soon, get it out of the stock market.



Jim Cramer is co-founder and chairman of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here.

TheStreet.com has a revenue-sharing relationship with Amazon.com under which it receives a portion of the revenue from Amazon.com purchases by customers directed there from TheStreet.com.



Brokerage Partners



Write us!
Order reprints of TSC articles.

TheStreet Premium Services
Jim Cramer
Jim Cramer's Action Alerts PLUS
Now any level of investor can trade right alongside a Wall Street pro — and enjoy 24/7 access to his portfolio! Learn More
Doug Kass
RealMoney Silver
The genius of Doug Kass + 5 Premium Services = an unrivaled group of expert fundamental analysts, technical analysts, and Wall Street observers. Learn More
Don Dion
NEW! Don Dion's ETF Action
A concise two-step strategy for learning and trading in this increasingly lucrative area of investing. For all levels of investors! Learn More
David Peltier
Stocks Under $10
David Peltier is ready to help you find affordable stocks under $10. Because they're so inexpensive, the payout could be enormous! Learn More
Bryan Ashenberg
Breakout Stocks
Bryan Ashenberg combines sophisticated screening software with eagle-eye analysis to find small and mid-caps ready to break out! Learn More

Investor Relations | Privacy Policy | Terms of Use | Conflicts Policy | Corrections | Internet Index | Advertise | FAQ
Site Map | Who's Who | Reader Feedback | Employment | Contact Us
RSSSubscribe to our RSS Feed
© 1996- TheStreet.com, Inc. All rights reserved.
TheStreet.com's enterprise databases running Oracle are professionally monitored and managed by Pythian Remote DBA.